A client is recently diagnosed with Crohn's disease and is beginning treatment. What first-line treatment does the nurse expect that the client will be placed on to decrease the inflammatory response?
A) Ciprofloxacin (Cipro)
B) Methotrexate (MTX)
C) Azathioprine (Imuran)
D) Sulfasalazine (Azulfidine)
D
Feedback:
Considered first-line treatment for inflammatory bowel disease, 5-ASA drugs contain salicylate, which is bonded to a carrying agent that allows the drug to be absorbed in the intestine. These drugs work by decreasing the inflammatory response. MTX or Imuran are used when failure to maintain remission necessitates the use of an immune-modulating agent. Cipro is used as an effective adjunct to treat the disease.
You might also like to view...
Federal and state departments of health regulatory agencies have been established to ensure optimal standards and delivery of care. Which action is the jurisdiction of these agencies?
a. Investigation of medication errors b. Investigation of patient- or family-reported complaints c. Investigation of patient falls d. Investigation of staffing shortages
A nursing instructor is teaching students about the Community Health Centers Act of 1963 . What was a deterring factor to the proper implementation of this act?
A. Many perspective clients did not meet criteria for mental illness diagnostic-related groups. B. Zoning laws discouraged the development of community mental health centers. C. States could not match federal funds to establish community mental health centers. D. There was not a sufficient employment pool to staff community mental health centers.
Which of the following is not true when assessing preterm fetuses?
A. FHR baseline may be in upper range of normal (150-160 bpm) B. They may have fewer accels, and if <35 weeks, may be 10x10 C. Variability may be in lower range for moderate (6-10 bpm)
Prior to initiating medication therapy with phenelzine (Nardil), the nurse should plan to deter-mine the client's:
1. Mood and affect 2. Activity level 3. Cognitive ability to understand information about the medication 4. Support network and its members' willingness to participate in treatment